Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04499339
What this trial is testing

A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wuerzburg University Hospital 38
Testing effectiveness (Phase 2)Study completedNCT04368507
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Recurrent
CellabMED 35
Testing effectiveness (Phase 2)Ended earlyNCT04097301
What this trial is testing

Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma

Who this might be right for
Acute Myeloid LeukemiaMultiple Myeloma
AGC Biologics S.p.A. 8
Early research (Phase 1)UnknownNCT05212987
What this trial is testing

Study of FCN-098 in Patients With Advanced Solid Tumor

Who this might be right for
Solid Tumor
Fochon Pharmaceuticals, Ltd. 43
Early research (Phase 1)Study completedNCT05981235
What this trial is testing

Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors

Who this might be right for
Gastrointestinal Tumors
Peking University 8
Early research (Phase 1)UnknownNCT05020119
What this trial is testing

Neoantigen-expanded Autologous Immune Cell Therapy

Who this might be right for
Advanced Solid Tumor
Chang Gung Memorial Hospital 9
Early research (Phase 1)Looking for participantsNCT07173595
What this trial is testing

A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Relapsed or Refractory Hematologic Malignancies
Qilu Pharmaceutical Co., Ltd. 186
Early research (Phase 1)Study completedNCT02551185
What this trial is testing

ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Celgene 20
Early research (Phase 1)Study completedNCT02316197
What this trial is testing

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Solid TumorsChronic Lymphocytic Leukemia
Merck KGaA, Darmstadt, Germany 31
Early research (Phase 1)Study completedNCT04577703
What this trial is testing

First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sunshine Lake Pharma Co., Ltd. 20
Early research (Phase 1)UnknownNCT06027346
What this trial is testing

Bio-008 in Subjects With Advanced or Metastatic Solid Tumours

Who this might be right for
Solid Tumor, Adult
Shijiazhuang Yiling Pharmaceutical Co. Ltd 60
Early research (Phase 1)Study completedNCT06422520
What this trial is testing

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 63
Testing effectiveness (Phase 2)Study completedNCT05267054
What this trial is testing

Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma With Ociperlimab (BGB-A1217) in Combination With Tislelizumab (BGB-A317) or Rituximab

Who this might be right for
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma
BeiGene 53
Early research (Phase 1)UnknownNCT05150405
What this trial is testing

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Solid TumorLymphoma, Non-Hodgkin
Qilu Pharmaceutical Co., Ltd. 54
Early research (Phase 1)Study completedNCT00395434
What this trial is testing

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Mateon Therapeutics 20
Early research (Phase 1)UnknownNCT05223595
What this trial is testing

Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
Changchun GeneScience Pharmaceutical Co., Ltd. 42
Early research (Phase 1)Looking for participantsNCT07348211
What this trial is testing

First in Human Study of SIM0610 in Solid Tumors

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more
Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT00306631
What this trial is testing

Determine the Antitumor Activity and Evaluate the Safety of MKC-1

Who this might be right for
Breast Cancer
CASI pharmaceuticals, Inc. 65
Early research (Phase 1)Study completedNCT03352531
What this trial is testing

Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Akesobio Australia Pty Ltd 99
Early research (Phase 1)UnknownNCT05114915
What this trial is testing

Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 144
Next Page